SCHEDULE: Alkeon Capital Discloses 2.1% Stake in Hinge Health
Beneficial Ownership Report
Alkeon Capital Management LLC and its founder, Panayotis D. Sparaggis, have disclosed a 2.1% beneficial ownership stake in Hinge Health, Inc. Class A Common Stock.
Summary
- Alkeon Capital Management LLC and Panayotis D. Sparaggis collectively reported beneficial ownership of 791,104 shares of Hinge Health, Inc. Class A Common Stock.
- This represents a 2.1% stake in the company's Class A Common Stock.
- The ownership is held with shared voting power and shared dispositive power by both reporting persons.
- The percentage is calculated based on 37,919,155 shares of Class A Common Stock outstanding as of October 30, 2025.
- This filing is an Amendment No. 1 to a Schedule 13G, indicating an update to a previous beneficial ownership disclosure for the period ending December 31, 2025.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a moderately positive signal, as a reputable institutional investor has taken or maintained a stake in Hinge Health, suggesting a degree of confidence in the company, though the filing itself is purely factual.
Positives
- An institutional investor, Alkeon Capital Management LLC, has taken or maintained a significant stake in Hinge Health, Inc., potentially signaling confidence in the company's long-term prospects.
- The disclosure of a 2.1% stake provides transparency regarding a notable institutional shareholder.
Future Outlook
The filing does not contain any forward-looking statements or guidance from Hinge Health, Inc. or the reporting persons regarding the company's future performance.
Industry Context
StockSavvy.ai notes that the disclosure of a 2.1% stake by Alkeon Capital Management, a prominent investment firm, in Hinge Health, a digital musculoskeletal health company, indicates continued institutional interest in the healthcare technology sector. This sector has seen significant investment as companies leverage technology to address chronic conditions and improve patient outcomes.
Comparison to Industry Standards
- This filing is a standard beneficial ownership disclosure (Schedule 13G) by an institutional investor.
- A 2.1% stake is a notable, but not controlling, position for an institutional investor in a publicly traded company.
- For example, similar filings by firms like BlackRock or Vanguard often disclose much larger passive stakes (e.g., 5-10% or more) across numerous companies, reflecting broad market index tracking or diversified investment strategies.
- Alkeon Capital's stake, while smaller, suggests a more active investment decision in Hinge Health specifically, rather than a broad index play.
Stakeholder Impact
- Shareholders: The disclosure of an institutional investor's stake can provide a level of validation for the company's prospects.
- Company Management: Awareness of a significant institutional holder may influence strategic decisions or communication.
Key Dates
| Date | Description |
|---|---|
| 2025-09-30 | End of quarterly period for which Hinge Health, Inc. filed its Form 10-Q. |
| 2025-10-30 | Date as of which 37,919,155 shares of Class A Common Stock were reported outstanding. |
| 2025-11-07 | Date Hinge Health, Inc. filed its Quarterly Report on Form 10-Q for the period ended September 30, 2025. |
| 2025-12-31 | Date of event which requires filing of this statement (reporting period end for beneficial ownership). |
| 2026-02-13 | Signature date of the Schedule 13G/A filing by Alkeon Capital Management LLC and Panayotis D. Sparaggis. |
Keywords
Hinge Health, Alkeon Capital Management, Panayotis D. Sparaggis, Beneficial Ownership, Schedule 13G, Class A Common Stock, Institutional Investor, Healthcare Technology, Digital Health
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.